相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Crystal Structure of N-Glycosylated Human Glypican-1 Core Protein STRUCTURE OF TWO LOOPS EVOLUTIONARILY CONSERVED IN VERTEBRATE GLYPICAN-1
Gabriel Svensson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
NSC 74859-mediated inhibition of STAT3 enhances the anti-proliferative activity of cetuximab in hepatocellular carcinoma
Wei Chen et al.
LIVER INTERNATIONAL (2012)
High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening
Yen Phung et al.
MABS (2012)
Anthracyclines disrupt telomere maintenance by telomerase through inducing PinX1 ubiquitination and degradation
B. Zhang et al.
ONCOGENE (2012)
Glypican-3: A new target for cancer immunotherapy
Mitchell Ho et al.
EUROPEAN JOURNAL OF CANCER (2011)
Recombinant soluble glypican 3 protein inhibits the growth of hepatocellular carcinoma in vitro
Mingqian Feng et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Structure of the protein core of the glypican Dally-like and localization of a region important for hedgehog signaling
Min-Sung Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Suppression of Glypican 3 Inhibits Growth of Hepatocellular Carcinoma Cells through Up-Regulation of TGF-β2
Chris K. Sun et al.
NEOPLASIA (2011)
Generation of a humanized anti-glypican 3 antibody by CDR grafting and stability optimization
Kiyotaka Nakano et al.
ANTI-CANCER DRUGS (2010)
Proapoptotic Kinase MST2 Coordinates Signaling Crosstalk between RASSF1A, Raf-1, and Akt
David Romano et al.
CANCER RESEARCH (2010)
Suppression of Liver Regeneration and Hepatocyte Proliferation in Hepatocyte-Targeted Glypican 3 Transgenic Mice
Bowen Liu et al.
HEPATOLOGY (2010)
Mammalian Ste20-like Kinase (Mst2) Indirectly Supports Raf-1/ERK Pathway Activity via Maintenance of Protein Phosphatase-2A Catalytic Subunit Levels and Consequent Suppression of Inhibitory Raf-1 Phosphorylation
Geoffrey K. Kilili et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Regulation of Proapoptotic Mammalian ste20-Like Kinase MST2 by the IGF1-Akt Pathway
Donghwa Kim et al.
PLOS ONE (2010)
Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver
Li Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis
Kwang-Pyo Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells
Kiyotaka Nakano et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 Oncogene
Dawang Zhou et al.
CANCER CELL (2009)
A Binding Domain on Mesothelin for CA125/MUC16
Osamu Kaneko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: A tissue microarray analysis of 4,387 tissue samples
Daniel Baumhoer et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Anti-Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer
Takahiro Ishiguro et al.
CANCER RESEARCH (2008)
N-glycosylation as novel strategy to improve pharmacokinetic properties of bispecific single-chain diabodies
Roland Stork et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Construction of a large phage-displayed human antibody domain library with a scaffold based on a newly identified highly soluble, stable heavy chain variable domain
Weizao Chen et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Structure of an IgNAR-AMA1 complex: Targeting a conserved hydrophobic cleft broadens malarial strain recognition
Kylie A. Henderson et al.
STRUCTURE (2007)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis
Josep M. Llovet et al.
GASTROENTEROLOGY (2006)
EGFR blockade by cetuximab alone or as combination therapy for growth control of hepatocellular cancer
A Huether et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Taming the hippo - Raf-1 controls apoptosis by suppressing MST2/Hippo
E O'Neill et al.
CELL CYCLE (2005)
Engineered antibody fragments and the rise of single domains
P Holliger et al.
NATURE BIOTECHNOLOGY (2005)
Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma
Y Hippo et al.
CANCER RESEARCH (2004)
Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies - African trypanosomes as paradigm
B Stijlemans et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Primary liver cancer:: Worldwide incidence and trends
FX Bosch et al.
GASTROENTEROLOGY (2004)
Glypican-3: A novel serum and histochemical marker for hepatocellular carcinoma
M Capurro et al.
GASTROENTEROLOGY (2003)
Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling
Y Midorikawa et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis
S Basu et al.
MOLECULAR CELL (2003)
Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders
ZW Zhu et al.
GUT (2001)
分享论文
